New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin‑6 production in tumor cells and KRAS co‑opted epigenetic mediators driving metabolic reprogramming
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.